IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,360 | -54.7% | 36 | -56.1% | 0.00% | -100.0% |
Q2 2022 | $3,000 | -50.0% | 82 | -46.4% | 0.00% | -50.0% |
Q1 2022 | $6,000 | -57.1% | 153 | -66.2% | 0.00% | -33.3% |
Q4 2021 | $14,000 | +250.0% | 453 | +287.2% | 0.00% | +50.0% |
Q3 2021 | $4,000 | -76.5% | 117 | -71.9% | 0.00% | -60.0% |
Q2 2021 | $17,000 | -10.5% | 417 | 0.0% | 0.01% | -16.7% |
Q1 2021 | $19,000 | +11.8% | 417 | +39.0% | 0.01% | -53.8% |
Q4 2020 | $17,000 | – | 300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |